Stay updated on Treprostinil Inhalation Powder in PAH Clinical Trial
Sign up to get notified when there's something new on the Treprostinil Inhalation Powder in PAH Clinical Trial page.

Latest updates to the Treprostinil Inhalation Powder in PAH Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.3 was added to the page footer. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe History page adds a new revision entry (v3.3.2) and removes the previous entry (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedA notice about a lapse in government funding/operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedA new history entry (Version 39, 2025-04-09) appears, updating the Recruitment Status, while the rest of the page layout remains essentially the same.SummaryDifference0.1%

- Check93 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference10%

- Check100 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.2%

Stay in the know with updates to Treprostinil Inhalation Powder in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Treprostinil Inhalation Powder in PAH Clinical Trial page.